Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bootstrapping01:24

Bootstrapping

612
The term "bootstrap" originated in the 19th century as a metaphor for self-improvement or achieving something independently, without external assistance. This concept extends to statistical bootstrapping, a self-contained method for estimating population parameters through resampling, even though it can be computationally intensive. Developed by the American statistician Dr. Bradley Efron in 1979, bootstrapping provides a robust way to perform inference when the original sample size is...
612
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

74
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
74
Distributions to Estimate Population Parameter01:26

Distributions to Estimate Population Parameter

4.1K
The accurate values of population parameters such as population proportion, population mean, and population standard deviation (or variance) are usually unknown. These are fixed values that can only be estimated from the data collected from the samples. The estimates of each of these parameters are sample proportion, the sample mean, and sample standard deviation (or variance). To obtain the values of these sample statistics, data are required that have particular distribution and central...
4.1K
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

44
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
44
Cluster Sampling Method01:20

Cluster Sampling Method

11.9K
Appropriate sampling methods ensure that samples are drawn without bias and accurately represent the population. Because measuring the entire population in a study is not practical, researchers use samples to represent the population of interest.
To choose a cluster sample, divide the population into clusters (groups) and then randomly select some of the clusters. All the members from these clusters are in the cluster sample. For example, if you randomly sample four departments from your...
11.9K
Biostatistics: Overview01:20

Biostatistics: Overview

254
Biostatistics plays a crucial role in understanding and analyzing data in healthcare and biology. Biostatisticians conduct experiments, gather evidence, and draw meaningful conclusions using statistical methods and techniques. Different variables form the foundation of biostatistical analysis, allowing researchers to understand and interpret data effectively. These variables are classified into different types, each serving a specific purpose in statistical analysis.
Discrete variables are...
254

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Staff experiences of percutaneous tracheostomy in intensive care: challenges, complications and potential solutions.

Anaesthesia reports·2026
Same author

Widening the gap: could residential 'simulated altitude prehabilitation' exacerbate health inequalities?

Anaesthesia·2024
Same author

The Nitrous Oxide Project: assessment of advocacy and national directives to deliver mitigation of anaesthetic nitrous oxide.

Anaesthesia·2024
Same author

Sustainability is a core outcome: filling research gaps in sustainable peri-operative care.

Anaesthesia·2024
Same author

Case of Erysipelas, Rheumatism, Jaundice, and Abortion, Followed by Puerperal Fever and Death.

Medical examiner (Philadelphia, Pa.)·2023
Same author

Tincture of Iodine in Small Pox.

Iowa medical journal·2023
Same journal

Implementing Project Optimus in Oncology Dosage Optimization: Where are We Now?

Therapeutic innovation & regulatory science·2026
Same journal

Validation of the Ontario Protocol Assessment Level (OPAL) Tool for Assessing Clinical Trial Complexity and Supporting Workforce Planning in the Italian Clinical Research Context.

Therapeutic innovation & regulatory science·2026
Same journal

The Effect of Covariate Adjustment for Cox Regression in Cardiovascular Outcome Trials.

Therapeutic innovation & regulatory science·2026
Same journal

Current Status and Construction Requirements of Drug Clinical Trial Institutions in Sichuan Province in China.

Therapeutic innovation & regulatory science·2026
Same journal

The CARE Program: An Initiative of Patient-Focused Drug Development for Rare Diseases by NMPA.

Therapeutic innovation & regulatory science·2026
Same journal

Utilization of Clinical Evaluation Reports in Japan's Medical Device Approvals: Insights from Review Data on Approved Devices.

Therapeutic innovation & regulatory science·2026
See all related articles

Related Experiment Video

Updated: Jul 12, 2025

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.4K

Using Bayesian Dynamic Borrowing to Maximize the Use of Existing Data: A Case-Study.

Dawn Edwards1, N Best2, J Crawford2

  • 1GSK, 980 Great West Road, Brentford, TW8 9GS, Middlesex, UK. dawn.m.webber@gsk.com.

Therapeutic Innovation & Regulatory Science
|November 1, 2023
PubMed
Summary
This summary is machine-generated.

Bayesian Dynamic Borrowing (BDB) enhances clinical drug development by integrating prior trial data. This robust approach strengthens evidence and increases trial efficiency, aiding regulatory submissions.

Keywords:
Bayesian dynamic borrowingCase-studyChinaClinical study data re-use

More Related Videos

Quantifying Cytoskeleton Dynamics Using Differential Dynamic Microscopy
06:37

Quantifying Cytoskeleton Dynamics Using Differential Dynamic Microscopy

Published on: June 15, 2022

3.6K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.2K

Related Experiment Videos

Last Updated: Jul 12, 2025

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.4K
Quantifying Cytoskeleton Dynamics Using Differential Dynamic Microscopy
06:37

Quantifying Cytoskeleton Dynamics Using Differential Dynamic Microscopy

Published on: June 15, 2022

3.6K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.2K

Area of Science:

  • Clinical Drug Development
  • Biostatistics
  • Regulatory Science

Background:

  • Bayesian Dynamic Borrowing (BDB) is increasingly adopted in clinical trials.
  • BDB offers a mathematically rigorous method for integrating existing data into new trials.
  • Regulatory acceptance of BDB is evolving and varies across agencies.

Purpose of the Study:

  • To describe the design of a new randomized clinical trial using BDB with external data.
  • To discuss key considerations for data re-use and BDB in drug development programs.
  • To present a case study on BDB for drug registration in China.

Main Methods:

  • Designing a randomized clinical trial incorporating external data via BDB.
  • Evaluating the appropriateness, selection, and weighting of external data for borrowing.
  • Assessing the successful demonstration of treatment benefit in the new study.

Main Results:

  • The paper details the application of BDB in designing clinical trials.
  • It addresses critical factors for effective data borrowing and integration.
  • A case study illustrates BDB's role in supporting drug registration.

Conclusions:

  • BDB provides a powerful framework for efficient and evidence-based clinical drug development.
  • Careful consideration of data selection, weighting, and regulatory guidelines is crucial for BDB implementation.
  • The presented case study demonstrates the practical application and evaluation of BDB in a regulatory context.